Oral antifungal therapy: Emerging culprits of cutaneous adverse drug reactions
Introduction: Antifungals are one of the most widely used drugs in dermatology practice for dermatophytosis. Oral antifungal therapy against superficial dermatophytosis is generally associated with a low incidence of adverse events in an immunocompetent population. However, lately, cutaneous adverse...
Main Authors: | Raju G Chaudhary, Santoshdev P Rathod, Ashish Jagati, Dhara Zankat, Arwinder K Brar, Bansri Mahadevia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Dermatology Online Journal |
Subjects: | |
Online Access: | http://www.idoj.in/article.asp?issn=2229-5178;year=2019;volume=10;issue=2;spage=125;epage=130;aulast=Chaudhary |
Similar Items
-
Cutaneous lupus erythematosus: An update
by: Carina M Grönhagen, et al.
Published: (2014-01-01) -
Subacute cutaneous lupus erythematosus following abemaciclib therapy for metastatic breast cancer
by: David J. Kurtyka, MS, et al.
Published: (2021-08-01) -
Lupus Erythematosus: Cutaneous Manifestations and Treatment
by: Francisca Alves, et al.
Published: (2019-10-01) -
Cutaneous drug reactions in childhood
by: Savaş Öztürk, et al.
Published: (2014-12-01) -
An Update on Adverse Cutaneous Drug Reactions in HIV/AIDS
by: Koraisha Hoosen, et al.
Published: (2019-06-01)